RenovoRx (RNXT) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free RNXT Stock Alerts $1.16 -0.01 (-0.85%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 30 at 8:30 AM | businesswire.comRenovoRx CEO Issues Update Letter to ShareholdersMay 21, 2024 | finance.yahoo.comPublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryMay 21, 2024 | businesswire.comPublication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx's TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment DeliveryMay 14, 2024 | finance.yahoo.comRenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024May 13, 2024 | investorplace.comRNXT Stock Earnings: RenovoRx Beats EPS for Q1 2024May 2, 2024 | businesswire.comRenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024April 26, 2024 | finance.yahoo.comRenovoRx Regains Compliance with Nasdaq Stockholders’ Equity RequirementApril 20, 2024 | investing.comRenovoRx meets Nasdaq stockholders equity requirementApril 18, 2024 | fr.investing.comRenovoRx répond aux exigences du Nasdaq en matière de capitaux propresApril 18, 2024 | businesswire.comRenovoRx Regains Compliance with Nasdaq Stockholders' Equity RequirementApril 16, 2024 | businesswire.comRenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingApril 15, 2024 | finance.yahoo.comRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026April 15, 2024 | businesswire.comRenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026April 8, 2024 | investorplace.comRNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023April 8, 2024 | investorplace.comRNXT Stock Earnings: RenovoRx Meets EPS for Q4 2023April 8, 2024 | businesswire.comRenovoRx Announces $11.1 Million at Market Private PlacementApril 5, 2024 | businesswire.comRenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024March 12, 2024 | finance.yahoo.comRenovoRx to Present at the 36th Annual ROTH Conference on March 19, 2024March 10, 2024 | investing.comRenovoRx announces key leadership promotionsMarch 8, 2024 | fr.investing.comRenovoRx annonce des promotions à des postes clésMarch 8, 2024 | finance.yahoo.comRenovoRx Highlights Key Leadership PromotionsFebruary 6, 2024 | fr.investing.comRenovoRx obtient un financement pour un essai de phase III sur le cancerJanuary 29, 2024 | msn.comRenovoRx closes $6.1M private placementJanuary 29, 2024 | finance.yahoo.comRenovoRx Closes $6.1 Million Private PlacementDecember 21, 2023 | finance.yahoo.comRenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct CancerDecember 19, 2023 | finance.yahoo.comRenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific MeetingDecember 13, 2023 | finance.yahoo.comRenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy PlatformDecember 9, 2023 | morningstar.comRenovoRx Inc RNXTNovember 16, 2023 | msn.comMaxim Group Downgrades RenovoRx (RNXT)November 16, 2023 | finance.yahoo.comRenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.November 14, 2023 | msn.comRenovoRx GAAP EPS of -$0.13November 14, 2023 | finance.yahoo.comRenovoRx Reports Third Quarter 2023 Financial Results and Operational HighlightsOctober 9, 2023 | finance.yahoo.comRenovoRx, Inc. (RNXT) Stock Historical Prices & Data - Yahoo FinanceOctober 2, 2023 | finance.yahoo.comRenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023August 18, 2023 | msn.comRoth MKM Maintains RenovoRx (RNXT) Buy RecommendationAugust 17, 2023 | finance.yahoo.comRenovoRx Reports Second Quarter 2023 Financial Results and Operational HighlightsJuly 31, 2023 | finance.yahoo.comRenovoRx to Present at the 43rd Annual Canaccord Genuity Growth ConferenceJuly 20, 2023 | finance.yahoo.comRenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) PlatformJuly 18, 2023 | barrons.comRenovoRx Inc.July 17, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Creative Medical Technology Holdings (CELZ), Boston Scientific (BSX) and RenovoRx (RNXT)July 11, 2023 | benzinga.comRenovoRx, Inc. Stock Presents A Compelling Value Proposition After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)July 5, 2023 | benzinga.comRenovoRx, Inc. Stock Surges After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)June 29, 2023 | msn.comWhy RenovoRx Stock Is Moving TodayJune 29, 2023 | finance.yahoo.comRenovoRx encountering "a lot of enthusiasm" for innovative cancer platformJune 29, 2023 | benzinga.comMicrocap Biotech Stock RenovoRx is Shooting Higher Today: Here's WhyJune 29, 2023 | finance.yahoo.comRenovoRx Announces New Positive Interim Phase III Data Demonstrating RenovoGem™ Delays Cancer Progression by Eight Months in Locally Advanced Pancreatic CancerJune 28, 2023 | benzinga.comCatalyst Watch: RenovoRx, Inc. Stock Jumps 14% Ahead of Thursday's Phase III TIGeR-PaC Trial Update ($RNXT)June 28, 2023 | markets.businessinsider.comPre-market Movers: ASTS, AREB, RNXT, COYA, BANL…June 26, 2023 | benzinga.comCatalyst Watch: RenovoRx, Inc. Nears June 29th Data Release From Its Phase III TIGeR-PaC Trial Targeting Pancreatic Cancer ($RNXT)June 20, 2023 | finance.yahoo.comRenovoRx Appoints Margaret A. Tempero, M.D., to Scientific Advisory Board Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now RNXT Media Mentions By Week RNXT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RNXT News Sentiment▼0.300.75▲Average Medical News Sentiment RNXT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RNXT Articles This Week▼31▲RNXT Articles Average Week Get RenovoRx News Delivered to You Automatically Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RMTI News CALC News NVCT News ADAG News KPTI News AMLX News CTXR News PDSB News COYA News IMUX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RNXT) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RenovoRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
